The Director of the Department of Public Health may, upon service of written notice, embargo any drug, device, or other substance for a period not to exceed fifteen days if such drug, device, or substance is suspected of being adulterated or misbranded, the purpose of such embargo being to prevent the removal of such drug, device, or substance from the jurisdiction of the Director of the Department of Public Health until an investigation of such suspected adulteration or misbranding may be conducted.